Novel adverse events of vortioxetine: A disproportionality analysis in USFDA adverse event reporting system database

The present study suggests that vortioxetine may result in these adverse events. Further pharmacoepidemiologic studies are necessary to confirm this conclusion and to improve the precision of the prevalence and/or the risk factors of this ADRs.